SCHEMBL8807356

SCHEMBL8807356

O=C(O)c1cc(-c2c(-c3ccccc3)nn3ccccc23)c[nH]c1=O

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.50
ADORA1 P30542 2/20 0.45
MAPK1 P28482 5/20 0.45
AKT1 P31749 1/20 0.43
MAPK14 Q16539 2/20 0.42
MAPK3 P27361 1/20 0.42
EGFR P00533 2/20 0.42
RAF1 P04049 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
GSK3B P49841 1/20 0.42
SPR P35270 1/20 0.39
KDM4E B2RXH2 1/20 0.37
DYRK1A Q13627 1/20 0.37
PDE4B Q07343 1/20 0.36
PDE3A Q14432 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8811408 0.81 MCL1 (0.56) IGF1RADORA1MAPK1AKT1MAPK14
SCHEMBL8809654 0.78 AKT1 (0.51) IGF1RADORA1MAPK1AKT1MAPK14
SCHEMBL8807929 0.76 IGF1R (0.48) IGF1RADORA1MAPK1AKT1MAPK14
SCHEMBL14502354 0.75 AKT1 (0.65) IGF1RADORA1MAPK1AKT1MAPK14
SCHEMBL8811997 0.74 IGF1R (0.55) IGF1RADORA1MAPK1AKT1MAPK14
SCHEMBL8809176 0.74 ADORA1 (0.52) IGF1RADORA1MAPK1AKT1MAPK14
SCHEMBL396923 0.73 AURKA (0.58) KDM4EDYRK1A
SCHEMBL8812720 0.72 AKT1 (0.50) IGF1RADORA1MAPK1AKT1MAPK14
SCHEMBL8810075 0.71 ADORA1 (0.44) IGF1RADORA1MAPK1AKT1EGFR
SCHEMBL7583881 0.70 BRD4 (0.40) IGF1RADORA1MAPK1AKT1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0810221-A1 OXYGEN-CONTAINING HETEROCYCLIC DERIVATIVES MITSUBISHI CHEMICAL CORPORATION (JP) 1997-12-03 EP disclosed
EP-0379979-B1 Pyrazolopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1997-03-19 EP disclosed
US-5155114-A Treating or preventing renal toxicity, nephrosis, nephritis FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-10-13 US disclosed
US-4985444-A Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-01-15 US disclosed
EP-0379979-A1 Pyrazolopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-08-01 EP disclosed